MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1212/wnl.0000000000003076

Медицинская библиотека · Neurology · 2016

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.

Walker Zuzana, Moreno Emilio, Thomas Alan, Inglis Fraser, Tabet Naji, Stevens Tim, Whitfield Tim, Aarsland Dag, Rainer Michael, Padovani Alessandro, DaTSCAN DLB Phase 4 Study Group

Клиническое исследование IV фазыСтатьяМногоцентровое исследованиеРандомизированное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core and suggestive features in patients with possible DLB over time depending on the (123)I-FP-CIT SPECT scan result.

METHODS

A total of 187 patients with possible DLB (dementia plus one core or one suggestive feature) were randomized to have dopamine transporter imaging or to follow-up without scan. DLB features were compared at baseline and at 6-month follow-up according to imaging results and follow-up diagnosis.

RESULTS

For the whole cohort, the baseline frequency of parkinsonism was 30%, fluctuations 29%, visual hallucinations 24%, and REM sleep behavior disorder 17%. Clinician-rated presence of parkinsonism at baseline was significantly (p = 0.001) more frequent and Unified Parkinson's Disease Rating Scale (UPDRS) score at baseline was significantly higher (p = 0.02) in patients with abnormal imaging. There was a significant increase in UPDRS score in the abnormal scan group over time (p < 0.01). There was relatively little evolution of the rest of the DLB features regardless of the imaging result.

CONCLUSIONS

In patients with possible DLB, apart from UPDRS score, there was no difference in the evolution of DLB clinical features over 6 months between cases with normal and abnormal imaging. Only parkinsonism and dopamine transporter imaging helped to differentiate DLB from non-DLB dementia.

Для цитирования: Walker Zuzana, Moreno Emilio, Thomas Alan, Inglis Fraser, Tabet Naji, Stevens Tim, Whitfield Tim, Aarsland Dag, Rainer Michael, Padovani Alessandro, DaTSCAN DLB Phase 4 Study Group. Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.. Neurology. 2016. DOI: 10.1212/wnl.0000000000003076.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.